Beckley Psytech Limited acquired Eleusis Therapeutics Limited. The companies are located in the UK. Terms of the deal were not disclosed.
Beckley Psytech is a clinical-stage privately held company helping patients suffering from neurological and psychiatric disorders by developing a pipeline of psychedelic compounds.
Founded in 2013, Eleusis is a clinical-stage life science company that aims to unlock the potential of psychedelics, guided by science and enabled by drug discovery, clinical development and care delivery design.
According to the LevinPro HC database, this was the 116th Biotechnology deal of 2022. That compares with 100 Biotechnology transactions recorded between January 1, 2021, and October 24, 2021.
